466 related articles for article (PubMed ID: 32762793)
1. Genetic correlation, pleiotropy, and causal associations between substance use and psychiatric disorder.
Jang SK; Saunders G; Liu M; ; Jiang Y; Liu DJ; Vrieze S
Psychol Med; 2022 Apr; 52(5):968-978. PubMed ID: 32762793
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive gene-centric pleiotropic association analysis for 14 psychiatric disorders with GWAS summary statistics.
Lu H; Qiao J; Shao Z; Wang T; Huang S; Zeng P
BMC Med; 2021 Dec; 19(1):314. PubMed ID: 34895209
[TBL] [Abstract][Full Text] [Related]
3. Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders: A Genome-Wide Pleiotropic Analysis.
Gong W; Guo P; Li Y; Liu L; Yan R; Liu S; Wang S; Xue F; Zhou X; Yuan Z
JAMA Psychiatry; 2023 Apr; 80(4):360-370. PubMed ID: 36753304
[TBL] [Abstract][Full Text] [Related]
4. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders.
;
Cell; 2019 Dec; 179(7):1469-1482.e11. PubMed ID: 31835028
[TBL] [Abstract][Full Text] [Related]
5. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
Jiang X; Deng Q; Stener-Victorin E
Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.
Jia X; Yang Y; Chen Y; Cheng Z; Du Y; Xia Z; Zhang W; Xu C; Zhang Q; Xia X; Deng H; Shi X
J Affect Disord; 2019 Jan; 242():234-243. PubMed ID: 30212762
[TBL] [Abstract][Full Text] [Related]
7. Pervasive pleiotropy between psychiatric disorders and immune disorders revealed by integrative analysis of multiple GWAS.
Wang Q; Yang C; Gelernter J; Zhao H
Hum Genet; 2015 Nov; 134(11-12):1195-209. PubMed ID: 26340901
[TBL] [Abstract][Full Text] [Related]
8. Genomic relationships across psychiatric disorders including substance use disorders.
Abdellaoui A; Smit DJA; van den Brink W; Denys D; Verweij KJH
Drug Alcohol Depend; 2021 Mar; 220():108535. PubMed ID: 33524898
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the shared genetic basis of migraine and mental disorders using novel statistical tools.
Bahrami S; Hindley G; Winsvold BS; O'Connell KS; Frei O; Shadrin A; Cheng W; Bettella F; Rødevand L; Odegaard KJ; Fan CC; Pirinen MJ; Hautakangas HM; ; Dale AM; Djurovic S; Smeland OB; Andreassen OA
Brain; 2022 Mar; 145(1):142-153. PubMed ID: 34273149
[TBL] [Abstract][Full Text] [Related]
10. Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.
Munn-Chernoff MA; Johnson EC; Chou YL; Coleman JRI; Thornton LM; Walters RK; Yilmaz Z; Baker JH; Hübel C; Gordon S; Medland SE; Watson HJ; Gaspar HA; Bryois J; Hinney A; Leppä VM; Mattheisen M; Ripke S; Yao S; Giusti-Rodríguez P; Hanscombe KB; Adan RAH; Alfredsson L; Ando T; Andreassen OA; Berrettini WH; Boehm I; Boni C; Boraska Perica V; Buehren K; Burghardt R; Cassina M; Cichon S; Clementi M; Cone RD; Courtet P; Crow S; Crowley JJ; Danner UN; Davis OSP; de Zwaan M; Dedoussis G; Degortes D; DeSocio JE; Dick DM; Dikeos D; Dina C; Dmitrzak-Weglarz M; Docampo E; Duncan LE; Egberts K; Ehrlich S; Escaramís G; Esko T; Estivill X; Farmer A; Favaro A; Fernández-Aranda F; Fichter MM; Fischer K; Föcker M; Foretova L; Forstner AJ; Forzan M; Franklin CS; Gallinger S; Giegling I; Giuranna J; Gonidakis F; Gorwood P; Gratacos Mayora M; Guillaume S; Guo Y; Hakonarson H; Hatzikotoulas K; Hauser J; Hebebrand J; Helder SG; Herms S; Herpertz-Dahlmann B; Herzog W; Huckins LM; Hudson JI; Imgart H; Inoko H; Janout V; Jiménez-Murcia S; Julià A; Kalsi G; Kaminská D; Karhunen L; Karwautz A; Kas MJH; Kennedy JL; Keski-Rahkonen A; Kiezebrink K; Kim YR; Klump KL; Knudsen GPS; La Via MC; Le Hellard S; Levitan RD; Li D; Lilenfeld L; Lin BD; Lissowska J; Luykx J; Magistretti PJ; Maj M; Mannik K; Marsal S; Marshall CR; Mattingsdal M; McDevitt S; McGuffin P; Metspalu A; Meulenbelt I; Micali N; Mitchell K; Monteleone AM; Monteleone P; Nacmias B; Navratilova M; Ntalla I; O'Toole JK; Ophoff RA; Padyukov L; Palotie A; Pantel J; Papezova H; Pinto D; Rabionet R; Raevuori A; Ramoz N; Reichborn-Kjennerud T; Ricca V; Ripatti S; Ritschel F; Roberts M; Rotondo A; Rujescu D; Rybakowski F; Santonastaso P; Scherag A; Scherer SW; Schmidt U; Schork NJ; Schosser A; Seitz J; Slachtova L; Slagboom PE; Slof-Op't Landt MCT; Slopien A; Sorbi S; Świątkowska B; Szatkiewicz JP; Tachmazidou I; Tenconi E; Tortorella A; Tozzi F; Treasure J; Tsitsika A; Tyszkiewicz-Nwafor M; Tziouvas K; van Elburg AA; van Furth EF; Wagner G; Walton E; Widen E; Zeggini E; Zerwas S; Zipfel S; Bergen AW; Boden JM; Brandt H; Crawford S; Halmi KA; Horwood LJ; Johnson C; Kaplan AS; Kaye WH; Mitchell J; Olsen CM; Pearson JF; Pedersen NL; Strober M; Werge T; Whiteman DC; Woodside DB; Grove J; Henders AK; Larsen JT; Parker R; Petersen LV; Jordan J; Kennedy MA; Birgegård A; Lichtenstein P; Norring C; Landén M; Mortensen PB; Polimanti R; McClintick JN; Adkins AE; Aliev F; Bacanu SA; Batzler A; Bertelsen S; Biernacka JM; Bigdeli TB; Chen LS; Clarke TK; Degenhardt F; Docherty AR; Edwards AC; Foo JC; Fox L; Frank J; Hack LM; Hartmann AM; Hartz SM; Heilmann-Heimbach S; Hodgkinson C; Hoffmann P; Hottenga JJ; Konte B; Lahti J; Lahti-Pulkkinen M; Lai D; Ligthart L; Loukola A; Maher BS; Mbarek H; McIntosh AM; McQueen MB; Meyers JL; Milaneschi Y; Palviainen T; Peterson RE; Ryu E; Saccone NL; Salvatore JE; Sanchez-Roige S; Schwandt M; Sherva R; Streit F; Strohmaier J; Thomas N; Wang JC; Webb BT; Wedow R; Wetherill L; Wills AG; Zhou H; Boardman JD; Chen D; Choi DS; Copeland WE; Culverhouse RC; Dahmen N; Degenhardt L; Domingue BW; Frye MA; Gäebel W; Hayward C; Ising M; Keyes M; Kiefer F; Koller G; Kramer J; Kuperman S; Lucae S; Lynskey MT; Maier W; Mann K; Männistö S; Müller-Myhsok B; Murray AD; Nurnberger JI; Preuss U; Räikkönen K; Reynolds MD; Ridinger M; Scherbaum N; Schuckit MA; Soyka M; Treutlein J; Witt SH; Wodarz N; Zill P; Adkins DE; Boomsma DI; Bierut LJ; Brown SA; Bucholz KK; Costello EJ; de Wit H; Diazgranados N; Eriksson JG; Farrer LA; Foroud TM; Gillespie NA; Goate AM; Goldman D; Grucza RA; Hancock DB; Harris KM; Hesselbrock V; Hewitt JK; Hopfer CJ; Iacono WG; Johnson EO; Karpyak VM; Kendler KS; Kranzler HR; Krauter K; Lind PA; McGue M; MacKillop J; Madden PAF; Maes HH; Magnusson PKE; Nelson EC; Nöthen MM; Palmer AA; Penninx BWJH; Porjesz B; Rice JP; Rietschel M; Riley BP; Rose RJ; Shen PH; Silberg J; Stallings MC; Tarter RE; Vanyukov MM; Vrieze S; Wall TL; Whitfield JB; Zhao H; Neale BM; Wade TD; Heath AC; Montgomery GW; Martin NG; Sullivan PF; Kaprio J; Breen G; Gelernter J; Edenberg HJ; Bulik CM; Agrawal A
Addict Biol; 2021 Jan; 26(1):e12880. PubMed ID: 32064741
[TBL] [Abstract][Full Text] [Related]
11. A Local Genetic Correlation Analysis Provides Biological Insights Into the Shared Genetic Architecture of Psychiatric and Substance Use Phenotypes.
Gerring ZF; Thorp JG; Gamazon ER; Derks EM
Biol Psychiatry; 2022 Oct; 92(7):583-591. PubMed ID: 35525699
[TBL] [Abstract][Full Text] [Related]
12. Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders.
Koller D; Mitjans M; Kouakou M; Friligkou E; Cabrera-Mendoza B; Deak JD; Llonga N; Pathak GA; Stiltner B; Løkhammer S; Levey DF; Zhou H; Hatoum AS; Kember RL; Kranzler HR; Stein MB; Corominas R; Demontis D; Artigas MS; Ramos-Quiroga JA; Gelernter J; Ribasés M; Cormand B; Polimanti R
Psychiatry Res; 2024 Mar; 333():115758. PubMed ID: 38335780
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel genomic risk loci shared between common epilepsies and psychiatric disorders.
Karadag N; Shadrin AA; O'Connell KS; Hindley GFL; Rahman Z; Parker N; Bahrami S; Fominykh V; Cheng W; Holen B; Alvestad S; Taubøll E; Steen NE; Djurovic S; Dale AM; Frei O; Andreassen OA; Smeland OB
Brain; 2023 Aug; 146(8):3392-3403. PubMed ID: 36757824
[TBL] [Abstract][Full Text] [Related]
14. Shared genetics of psychiatric disorders and type 2 diabetes:a large-scale genome-wide cross-trait analysis.
Ding H; Xie M; Wang J; Ouyang M; Huang Y; Yuan F; Jia Y; Zhang X; Liu N; Zhang N
J Psychiatr Res; 2023 Mar; 159():185-195. PubMed ID: 36738649
[TBL] [Abstract][Full Text] [Related]
15. The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study.
Cheng W; Parker N; Karadag N; Koch E; Hindley G; Icick R; Shadrin A; O'Connell KS; Bjella T; Bahrami S; Rahman Z; Tesfaye M; Jaholkowski P; Rødevand L; Holen B; Lagerberg TV; Steen NE; Djurovic S; Dale AM; Frei O; Smeland OB; Andreassen OA
Lancet Psychiatry; 2023 Jun; 10(6):441-451. PubMed ID: 37208114
[TBL] [Abstract][Full Text] [Related]
16. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
Cross-Disorder Group of the Psychiatric Genomics Consortium
Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885
[TBL] [Abstract][Full Text] [Related]
17. Cross-trait genome-wide association analysis of C-reactive protein level and psychiatric disorders.
Hindley G; Drange OK; Lin A; Kutrolli G; Shadrin AA; Parker N; O'Connell KS; Rødevand L; Cheng W; Bahrami S; Karadag N; Holen B; Jaholkowski P; Woldeyohannes MT; Djurovic S; Dale AM; Frei O; Ueland T; Smeland OB; Andreassen OA
Psychoneuroendocrinology; 2023 Nov; 157():106368. PubMed ID: 37659117
[TBL] [Abstract][Full Text] [Related]
18. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
19. Common genetic substrates of alcohol and substance use disorder severity revealed by pleiotropy detection against GWAS catalog in two populations.
Peng Q; Wilhelmsen KC; Ehlers CL
Addict Biol; 2021 Jan; 26(1):e12877. PubMed ID: 32027075
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study of psychiatric and substance use comorbidity in Mexican individuals.
Martínez-Magaña JJ; Genis-Mendoza AD; Villatoro Velázquez JA; Bustos-Gamiño M; Juárez-Rojop IE; Tovilla-Zarate CA; Sarmiento E; Saucedo E; Rodríguez-Mayoral O; Fleiz-Bautista C; Camarena B; Aguilar A; Gonzalez-Castro TB; Medina-Mora ME; Nicolini H
Sci Rep; 2021 Mar; 11(1):6771. PubMed ID: 33762635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
